Justine E Marum, PhD^1*, Leanne Purins, PhD^2*, David T Yeung, BSc, MBBS, FRACP, FRCPA^3,4,5, Wendy Tara Parker, PhD^6*, David J Price, PhD^7*, Paul PS Wang, PhD^1*, Doris Stangl, PhD^1*, Jasmina Geogievski, BSc^2*, Bradley Chereda, PhD^1*, Andreas Schreiber, PhD^1*, Simon J Tuke, PhD^7*, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA⁸ and Susan Branford, PhD FFSc (RCPA)^2,5,9,10

¹Centre for Cancer Biology, SA Pathology, Adelaide, Australia
²Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia
³Haematology, SA Pathology, Adelaide, Australia
⁴Department of Genetics and Molecular Pathology, Centre for Cancer Biology, Adelaide, Australia
⁵School of Medicine, University of Adelaide, Adelaide, Australia
⁶SA Pathology, Adelaide, Australia
⁷School of Mathematical Sciences, University of Adelaide, Adelaide, Australia
⁸SA Pathology and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia
⁹School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia
¹⁰Centre for Cancer Biology, SA Pathology, University of Adelaide, Adelaide, Australia

Jae-Yong Kwak¹, Hawk Kim², Jeong A Kim³, Young Rok Do⁴, Hyeoung Joon Kim, MD, PhD⁵, Joon Seong Park⁶, Joo Seop Chung, MD, PhD⁷, Ho-Jin Shin⁸, Sung-Hyun Kim⁹, Dae-Young Kim, MD, PhD¹⁰, Udomsak Bunworasate¹¹, Chul Won Choi, MD, PhD^12*, Narcisa Sonia Cornejo Comia^13*, Dae Young Zang^14*, Sukjoong Oh¹⁵, Saengsuree Jootar¹⁶, Ary Harryanto Reksodiputro^17*, Won Sik Lee¹⁸, Yeung-Chul Mun¹⁹, Jee Hyun Kong^20*, Priscilla B. Caguioa^21*, Jinny Park²², Chul Won Jung²³ and Dong-Wook Kim²⁴

¹Chonbuk National University Medical School & Hospital, Jeonju, South Korea
²Ulsan University Hospital, Ulsan, South Korea
³St. Vincent Hospital, The Catholic University of Korea, Suwon, South Korea
⁴Dongsan Medical Center, Keimyung University, Daegu, South Korea
⁵Chonnam National University Hwasun Hospital, Kwangju, South Korea
⁶Ajou University Hospital, Seoul, South Korea
⁷Pusan National University Hospital, Pusan, South Korea
⁸Pusan National University Hospital, Busan, South Korea
⁹Dong-A University Medical Center, Busan, South Korea
¹⁰Department of Hematology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea
¹¹King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand
¹²Korea University Medical Center, Guro Hospital, Seoul, South Korea
¹³Mary Mediatrix Medical Center, Lipa City, Philippines
¹⁴Hallym University Sacred Heart Hospital, Anyang, South Korea
¹⁵Kangbuk Samsung Hospital, Seoul, South Korea
¹⁶Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
¹⁷Rumah Sakit Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
¹⁸Inje University Busan Paik Hospital, Busan, South Korea
¹⁹Ewha Womans University Mokdong Hospital, Seoul, South Korea
²⁰Wonju Severance Christian Hospital,, Wonju, South Korea
²¹St. Luke’s Medical Center, Manila, Philippines
²²Gachon University Gil Medical Center, Incheon, South Korea
²³Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
²⁴Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea

Henrik Hjorth-Hansen, MD, PhD^1,2, Jesper Stentoft^3*, Johan Richter, MD, PhD^4,5*, Perttu Koskenvesa, MD^6*, Arta Dreimane, MD^7,8*, Kimmo Porkka, MD, PhD⁶, Tobias Gedde-Dahl, MD PhD^9,10*, Bjorn Gjertsen, MD, PhD¹¹, Franz X. Gruber, MD PhD^12*, Martin Hoglund, MD, PhD¹³, Anna Lubking, MD^14*, Kristina Myhr-Eriksson, MD^15*, Berit Markevärn^16*, Hanne Vestergaard, MD PhD^17*, Ole Weis Bjerrum, MD PhD^18*, Leif Stenke, MD PhD¹⁹, Satu Mustjoki, MD, PhD²⁰ and Ulla Stromberg, MD PhD^21*

¹Dept of Cancer Researc and Molecular Medicine (IKM), Norwegian University of Science and Technology (NTNU), Trondheim, Norway
²Dept of Hematology, St Olavs Hospital, Trondheim, Norway
³Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
⁴Department of Molecular Medicine and Gene Therapy and Department of Hematology and Vascular Disorders, Lund University and Skåne University Hospital, Lund, Sweden
⁵Department of Hematology and Vascular Disorders, Skane University Hospital, Lund, Sweden
⁶Hematology Research Unit Helsinki, University of Helsinki and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
⁷Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
⁸Dept of Hematology, County Council of Östergötland, Linköping, Sweden
⁹Oslo University Hospital, Oslo, Norway
¹⁰Dept of Internal Medcine, Oslo University Hospital, Oslo, Norway
¹¹Dept of Internal Medicine, Haukeland University Hospital, Bergen, Norway
¹²Dept of Internal Medicine, University Hospital in North Norway, Tromsö, Norway
¹³Uppsala University, Department of Medical Sciences, Section of Hematology, Uppsala, Sweden
¹⁴Department of Hematology and Vascular Disorders, Skåne University Hospital, Lund, Sweden
¹⁵Dept of Internal Medicine, Sunderby Hospital, Luleå, Sweden
¹⁶Dept of Hematology, Umeå University Hospital, Umeå, Sweden
¹⁷Dept of Hematology, Odense University Hospital, Odense, Denmark
¹⁸Dept of Hematology, Rigshospitalet, Copenhagen, Denmark
¹⁹Division of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
²⁰Department of Hematology, University of Helsinki and Department of Hematology, Helsinki University Central Hospital Comprehensive Cancer Center, Helsinki, Finland
²¹Dept of Hematology, Uppsala University Hospital, Uppsala, Sweden

Michael W. Schmitt, MD, PhD^1,2, Justin R. Pritchard, PhD^3*, Graeme Hodgson, PhD^3*, Victor M. Rivera, PhD³, Bella I. Aminov^4*, Lan Beppu^2*, Lawrence A. Loeb, MD, PhD^4* and Jerald P. Radich²

¹Department of Medicine, Divisions of Hematology and Medical Oncology, University of Washington, Seattle, WA
²Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
³ARIAD Pharmaceuticals, Inc., Cambridge, MA
⁴Department of Pathology, University of Washington, Seattle, WA

Francis J. Giles, MB, MD, FRCPI, FRCPath¹, Delphine Rea, MD, PhD^2*, Michele Baccarani³, Nicholas C.P. Cross, PhD⁴, Juan Luis Steegmann, MD⁵, Laimonas Griskevicius^6,7*, Philipp le Coutre^8*, Daniel Coriu^9*, Ljubomir Petrov, MD, PhD^10*, Gert J. Ossenkoppele, MD, PhD¹¹, Francois-Xavier Mahon¹², Martin C. Müller, MD^13*, Andrzej Hellmann, MD, PhD¹⁴, Kimmo Porkka, MD, PhD¹⁵, Timothy H. Brümmendorf¹⁶, Gunther Gastl, MD, Prof,¹⁷, Viviana Tubazio^18*, Angela Pellegrino^18*, Luca Dezzani^19*, Gianantonio Rosti, MD^20* and Andreas Hochhaus, MD²¹

¹Institute for Drug Development, Cancer Therapy and Research Center at The UT Health Science Center at San Antonio, San Antonio, TX
²Fi-LMC group, Pessac, France
³Institute of Hematology, University of Bologna, Bologna, Italy
⁴Wessex Regional Genetics Laboratory, University of Southampton, Salisbury, United Kingdom
⁵Hematology Dpt. IIS-IP, Hospital Universitario de la Princesa, Madrid, Spain
⁶Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania
⁷WEST EXPRESS, GOSTAUTO 40A, VILNIUS 01112, VILNIUS, Lithuania
⁸Charité - University of Medicine Berlin Campus Virchow, Berlin, Germany
⁹Institutul Clinic Fundeni, Bucharest, Romania
¹⁰Ion Chiricuta Instititute of Oncology, Cluj-Napoca, Romania
¹¹Department of Hematology, VU University Medical Center, Amsterdam, Netherlands
¹²Hematology Laboratory, Bordeaux University,Bordeaux Hospital, INSERM 1035, BORDEAUX, France
¹³Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany
¹⁴Department of Hematology, Medical University of Gdansk, Gdansk, Poland
¹⁵Hematology Research Unit Helsinki, University of Helsinki and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
¹⁶Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University Hospital, Aachen, Germany
¹⁷Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria
¹⁸Novartis Oncology Region Europe, Origgio, Italy
¹⁹NOVARTIS ONCOLOGY ITALY, Origgio Varese, Italy
²⁰"Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
²¹Department of Hematology and Oncology, University Hospital Jena, Jena, Germany

Franck E. Nicolini, MD, PhD¹, Grzegorz W. Basak, MD, PhD^2*, Dong-Wook Kim, MD, PhD³, Eduardo Olavarria, MD, PhD^4*, Javier Pinilla-Ibarz, MD, PhD^5*, Jane F. Apperley, MD⁶, Timothy P. Hughes, MD⁷, Dietger Niederwieser, MD⁸, Michael J. Mauro, MD⁹, Charles Chuah, MD, PhD¹⁰, Andreas Hochhaus, MD¹¹, Giovanni Martinelli, MD, PhD¹², Maral DerSarkissian, PhD^13*, Andrew Kageleiry, BS^14*, Mo Yang, PhD^15*, Hui Huang, MBA, PhD^15*, Lisa J. McGarry, MPH^15*, Hagop M. Kantarjian, MD¹⁶ and Jorge E. Cortes, MD¹⁷

¹Centre Hospitalier Lyon Sud, Pierre-Bénite, France
²Medical University of Warsaw, Warsaw, Poland
³Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea
⁴Hammersmith Hospital, Imperial College, London, United Kingdom
⁵H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶Haematology Department, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
⁷Royal Adelaide Hospital, SA Pathology, Adelaide, Australia
⁸Hematology and Oncology, University of Leipzig, Leipzig, Germany
⁹Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Singapore General Hospital, Singapore, Singapore
¹¹Universitätsklinikum Jena, Jena, Germany
¹²Bologna University School of Medicine, Bologna, Italy
¹³Analysis Group, Inc., Los Angeles, CA
¹⁴Analysis Group, Inc., Boston, MA
¹⁵ARIAD Pharmaceuticals, Inc., Cambridge, MA
¹⁶Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁷Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX